Oak Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.9M | Sell |
110,466
-14,795
| -12% | -$5.27M | 2.62% | 12 |
|
|
2025
Q4 | $41M | Buy |
125,261
+475
| +0.4% | +$151K | 2.46% | 13 |
|
|
2025
Q3 | $35.2M | Sell |
124,786
-1,231
| -1% | -$357K | 2.15% | 15 |
|
|
2025
Q2 | $35.2M | Buy |
126,017
+2,410
| +2% | +$683K | 2.3% | 15 |
|
|
2025
Q1 | $38.5M | Sell |
123,607
-46
| -0% | -$13.6K | 2.89% | 10 |
|
|
2024
Q4 | $32.2M | Sell |
123,653
-315
| -0.3% | -$93.5K | 2.22% | 16 |
|
|
2024
Q3 | $39.9M | Sell |
123,968
-1,332
| -1% | -$436K | 2.69% | 12 |
|
|
2024
Q2 | $39.1M | Sell |
125,300
-376
| -0.3% | -$110K | 2.6% | 13 |
|
|
2024
Q1 | $35.7M | Sell |
125,676
-1,740
| -1% | -$509K | 2.48% | 11 |
|
|
2023
Q4 | $36.7M | Sell |
127,416
-1,222
| -0.9% | -$333K | 2.78% | 10 |
|
|
2023
Q3 | $34.6M | Sell |
128,638
-873
| -0.7% | -$218K | 2.88% | 9 |
|
|
2023
Q2 | $28.8M | Sell |
129,511
-18,203
| -12% | -$4.22M | 2.3% | 14 |
|
|
2023
Q1 | $35.7M | Sell |
147,714
-270
| -0.2% | -$66.3K | 2.94% | 9 |
|
|
2022
Q4 | $38.9M | Sell |
147,984
-5,777
| -4% | -$1.55M | 3.26% | 6 |
|
|
2022
Q3 | $34.7M | Sell |
153,761
-748
| -0.5% | -$181K | 2.94% | 9 |
|
|
2022
Q2 | $37.6M | Sell |
154,509
-1,141
| -0.7% | -$280K | 2.94% | 10 |
|
|
2022
Q1 | $37.6M | Sell |
155,650
-5,619
| -3% | -$1.29M | 2.3% | 10 |
|
|
2021
Q4 | $36.3M | Sell |
161,269
-2,230
| -1% | -$471K | 1.93% | 17 |
|
|
2021
Q3 | $34.8M | Sell |
163,499
-81
| -0% | -$18.6K | 1.98% | 16 |
|
|
2021
Q2 | $39.9M | Sell |
163,580
-732
| -0.4% | -$180K | 2.26% | 12 |
|
|
2021
Q1 | $40.9M | Sell |
164,312
-1,359
| -0.8% | -$324K | 2.42% | 11 |
|
|
2020
Q4 | $38.1M | Sell |
165,671
-1,625
| -1% | -$375K | 2.3% | 12 |
|
|
2020
Q3 | $42.5M | Sell |
167,296
-4,968
| -3% | -$1.23M | 2.84% | 10 |
|
|
2020
Q2 | $40.6M | Sell |
172,264
-4,712
| -3% | -$1.08M | 2.73% | 9 |
|
|
2020
Q1 | $35.9M | Sell |
176,976
-37,813
| -18% | -$8.26M | 2.94% | 10 |
|
|
2019
Q4 | $51.8M | Sell |
214,789
-7,646
| -3% | -$1.69M | 3.05% | 7 |
|
|
2019
Q3 | $43M | Sell |
222,435
-5,529
| -2% | -$1.06M | 2.65% | 10 |
|
|
2019
Q2 | $42M | Buy |
227,964
+8,843
| +4% | +$1.58M | 2.62% | 9 |
|
|
2019
Q1 | $41.6M | Sell |
219,121
-7,240
| -3% | -$1.38M | 2.54% | 9 |
|
|
2018
Q4 | $44.1M | Buy |
226,361
+10,703
| +5% | +$2.09M | 3.11% | 8 |
|
|
2018
Q3 | $44.7M | Buy |
215,658
+81
| +0% | +$16K | 2.73% | 8 |
|
|
2018
Q2 | $39.8M | Sell |
215,577
-67
| -0% | -$11.9K | 2.66% | 9 |
|
|
2018
Q1 | $36.8M | Sell |
215,644
-16
| -0% | -$2.94K | 2.56% | 9 |
|
|
2017
Q4 | $37.5M | Sell |
215,660
-106
| -0% | -$18.8K | 2.66% | 9 |
|
|
2017
Q3 | $40.2M | Sell |
215,766
-74
| -0% | -$13.1K | 2.96% | 8 |
|
|
2017
Q2 | $37.2M | Buy |
215,840
+4,503
| +2% | +$732K | 2.8% | 8 |
|
|
2017
Q1 | $34.7M | Sell |
211,337
-504
| -0.2% | -$83.7K | 2.77% | 8 |
|
|
2016
Q4 | $31M | Sell |
211,841
-13,295
| -6% | -$2M | 3.06% | 8 |
|
|
2016
Q3 | $31.8M | Buy |
225,136
+12,521
| +6% | +$2.12M | 3.27% | 7 |
|
|
2016
Q2 | $32.3M | Buy |
212,615
+1,905
| +0.9% | +$296K | 3.88% | 3 |
|
|
2016
Q1 | $31.6M | Buy |
210,710
+581
| +0.3% | +$86.3K | 3.87% | 3 |
|
|
2015
Q4 | $34.1M | Sell |
210,129
-3,080
| -1% | -$484K | 4.06% | 4 |
|
|
2015
Q3 | $29.5M | Buy |
213,209
+5,575
| +3% | +$879K | 3.91% | 5 |
|
|
2015
Q2 | $31.9M | Sell |
207,634
-1,639
| -0.8% | -$263K | 3.88% | 4 |
|
|
2015
Q1 | $33.5M | Sell |
209,273
-60
| -0% | -$9.45K | 4.02% | 3 |
|
|
2014
Q4 | $33.3M | Sell |
209,333
-2,385
| -1% | -$372K | 3.99% | 3 |
|
|
2014
Q3 | $29.7M | Sell |
211,718
-1,099
| -0.5% | -$143K | 3.66% | 5 |
|
|
2014
Q2 | $25.2M | Sell |
212,817
-4,675
| -2% | -$541K | 3.08% | 6 |
|
|
2014
Q1 | $26.8M | Sell |
217,492
-59,225
| -21% | -$7.18M | 3.32% | 6 |
|
|
2013
Q4 | $31.6M | Buy |
+276,717
| New | +$31.5M | 3.41% | 8 |
|
|
2013
Q2 | $34M | Buy |
+344,661
| New | +$35.8M | 4.05% | 6 |
|
Other funds holding AMGN
VCM
VPM
Oak Associates's AMGN Position: Q1 2026 in Review
Oak Associates reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $5.27M and leaving 110,466 shares worth $38.9M. The position accounts for 2.62% of the portfolio, ranked #12.
Oak Associates first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $51.8M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Oak Associates held 110,466 shares of Amgen worth $38.9M as of Q1 2026.
- Oak Associates sold 14,795 Amgen shares in Q1 2026, an estimated $5.27M.
- Amgen made up 2.62% of Oak Associates's portfolio in Q1 2026, its #12 holding.
- Oak Associates first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
- Oak Associates's Amgen position peaked at $51.8M in Q4 2019.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Oak Associates's 13F filing for Q1 2026, filed 14 May 2026.